IthaChrom

Ret. time (minutes) From: To:
Area (%) From: To:
ID Hb Variant Gene Instrument Method Area (%) Ret Time (min) Comments
ID Hb Variant Gene Instrument Method Comments
3Hb I-Interlakenα1D-10Dual Kit Program24.51.45Heterozygous[PDF]
6HbSβD-10Dual Kit Program34.24.06Heterozygous[PDF]
14HbCβD-10Dual Kit Program82.54.82Compound heterozygous with CD 39. Could be confused with HbC homozygous. A2 level and hematological data suggest an associated beta-thal.[PDF]
26HbEβD-10Dual Kit Program28.93.15Heterozygous[PDF]
27HbSβD-10Dual Kit Program52.74.04Compound heterozygote between HbS and HPFH [PDF]
45HbSβD-10Dual Kit Program21.34.11heterozygote[PDF]
49Hb SiirtβD-10Dual Kit Program80.51.69heterozygote[PDF]
52Hb G-Honoluluα1 or α2D-10Dual Kit Program19.43.83[PDF]
55Hb St. Claudeα1 or α2D-10Dual Kit Program21.81.42[PDF]
58Hb G-CoushattaβD-10Dual Kit Program352.7homozygote[PDF]
61Hb CamdenβD-10Dual Kit Program50.10.75[PDF]
65Hb DhofarβD-10Dual Kit Program23.53.43[PDF]
70Hb Pierre-BéniteβD-10Dual Kit Program83.31.66[PDF]
73Hb BicêtreβD-10Dual Kit Program83.41.69[PDF]
77Hb M-SaskatoonβD-10Dual Kit Program6.94.7[PDF]
81Hb RainierβD-10Dual Kit Program73.21.69[PDF]
85Hb J-BaltimoreβD-10Dual Kit Program42.91.52[PDF]
89Hb AcharnesβD-10Dual Kit Program81.71.7[PDF]
93Hb Chadα1 or α2D-10Dual Kit Program22.54.49[PDF]
97Hb Roanneα1 or α2D-10Dual Kit Program871.7heterozygote[PDF]
101Hb ProvidenceβD-10Dual Kit Program16.40.97[PDF]
102Hb Toulonα2D-10Dual Kit Program33.52.96heterozygote[PDF]
105Hb D-Ouled RabahβD-10Dual Kit Program48.32.64heterozygote[PDF]
109Hb Lyon-Bronα2D-10Dual Kit Program28.71.42[PDF]
114Hb Saint-JacquesβD-10Dual Kit Program76.11.72[PDF]
120Hb Gerlandα2D-10Dual Kit Program87.41.68[PDF]
125Hb AubagneβD-10Dual Kit Program82.71.69[PDF]
129Hb Stanleyville-IIα2D-10Dual Kit Program31.24.01[PDF]
133Hb J-Sardegnaα2D-10Dual Kit Program300.51[PDF]
137Hb Russα1D-10Dual Kit Program15.34.09[PDF]
141Hb K WoolwichβD-10Dual Kit Program33.50.65
145Hb MaputoβD-10Dual Kit Program553.5[PDF]
149Hb Brem-sur-MerβD-10Dual Kit Program721.72[PDF]
153Hb Fannin-Lubbock IIβD-10Dual Kit Program341.54[PDF]
157Hb Passyα2D-10Dual Kit Program74.71.68[PDF]
159Hb Handsworthα1D-10Dual Kit Program14.94.17[PDF]
161Hb Shimonosekiα1 or α2D-10Dual Kit Program14.74.17[PDF]
165Hb Lombardα2D-10Dual Kit Program0.52.55[PDF]
170Hb J-Tongarikiα1 or α2D-10Dual Kit Program20.31.59[PDF]
174Hb D-IranβD-10Dual Kit Program452.64compound heterozygote between HbS and Hb D-Iran[PDF]
178Hb YaoundeβD-10Dual Kit Program731.72[PDF]
182Hb Dunnα1 or α2D-10Dual Kit Program14.43.8heterozygote[PDF]
186Hb J-Torontoα1 or α2D-10Dual Kit Program17.91.58[PDF]
190Hb Chicagoα2D-10Dual Kit Program82.31.69[PDF]
195Hb HikariβD-10Dual Kit Program73.71.72[PDF]
199Hb G-SzuhuβD-10Dual Kit Program32.24.17[PDF]
203Hb Ambroise Pareα2D-10Dual Kit Program79.71.67[PDF]
207Hb Groene Hartα1D-10Dual Kit Program79.61.68[PDF]
211Hb Q-Thailandα1D-10Dual Kit Program22.54.18heterozygote[PDF]
216Hb Milledgevilleα1 or α2D-10Dual Kit Program5.81.44[PDF]
220Hb Nunobikiα1 or α2D-10Dual Kit Program5.81.44[PDF]
224Hb Summer HillβD-10Dual Kit Program35.83.88heterozygote[PDF]
226Hb Fort de Franceα1 or α2D-10Dual Kit Program64.11.66heterozygote[PDF]
228Hb J-Broussaisα1 or α2D-10Dual Kit Program141.12[PDF]
230HbSβD-10Dual Kit Program83.34.02[PDF]
232Hb Fort de Franceα1 or α2D-10Dual Kit Program16.13.06heterozygote[PDF]
233Hb K-IbadanβD-10Dual Kit Program7.81.38heterozygote[PDF]
236HbSβD-10Dual Kit Program88.54.04[PDF]
241HbSβD-10Dual Kit Program70.34.04[PDF]
247HbSβD-10Dual Kit Program23.34.1[PDF]
251HbSβD-10Dual Kit Program74.14.07[PDF]
254Hb G-Philadelphiaα1 or α2D-10Dual Kit Program303.92[PDF]
258HbCβD-10Dual Kit Program264.7[PDF]
262HbSβD-10Dual Kit Program74.84.04[PDF]
265HbCβD-10Dual Kit Program32.34.7heterozygote[PDF]
269Hb D-IranβD-10Dual Kit Program14.32.59heterozygote[PDF]
273Hb Hasharonα1D-10Dual Kit Program21.54.53heterozygote[PDF]
277Hb Hopkins-IIα1 or α2D-10Dual Kit Program18.31.41heterozygote[PDF]
281Hb J-BangkokβD-10Dual Kit Program39.81.68heterozygote[PDF]
285Hb J-Broussaisα1 or α2D-10Dual Kit Program31.10.96heterozygote[PDF]
289Hb J-Paris-Iα1D-10Dual Kit Program25.51.5heterozygote[PDF]
293Hb J-Sardegnaα2D-10Dual Kit Program36.10.46heterozygote[PDF]
297Hb Le Lamentinα2D-10Dual Kit Program24.81.36heterozygote[PDF]
301Hb O-ArabβD-10Dual Kit Program29.44.57heterozygote[PDF]
305Hb O-Padovaα1 or α2D-10Dual Kit Program14.24.42heterozygote[PDF]
309Hb Q-Indiaα1D-10Dual Kit Program14.84.37heterozygote[PDF]
313HbSβD-10Dual Kit Program32.44.08[PDF]
317Hb D-IbadanβD-10Dual Kit Program34.13.51[PDF]
321Hb VallettaβD-10Dual Kit Program84.11.69[PDF]
327Hb St. Luke'sα1D-10Dual Kit Program8.54.21[PDF]
331Hb Sunshine Sethα2D-10Dual Kit Program14.84.43heterozygote[PDF]
335HbEβD-10Dual Kit Program87.32.87[PDF]
339Hb TacomaβD-10Dual Kit Program67.51.7[PDF]
343Hb Old Dominion/Burton-upon-Trent (OD/BuT)βD-10Dual Kit Program36.31.52heterozygote[PDF]
347Hb Hopkins-IIα1 or α2D-10Dual Kit Program21.41.39[PDF]
351Hb G-Philadelphiaα1 or α2D-10Dual Kit Program22.53.96heterozygote[PDF]
357Hb Goudaα2D-10Dual Kit Program28.71.43heterozygote[PDF]
361HbCβD-10Dual Kit Program75.54.69[PDF]
365Hb Le Lamentinα2D-10Dual Kit Program28.81.38heterozygote[PDF]
369Hb J-Meerutα2D-10Dual Kit Program9.11.42heterozygote[PDF]
373Hb Winnipegα1D-10Dual Kit Program16.74.46[PDF]
376Hb Seal Rockα2D-10Dual Kit Program1.54.59[PDF]
380Hb D-PunjabβD-10Dual Kit Program38.13.78heterozygote[PDF]
384Hb G-AccraβD-10Dual Kit Program40.63.53[PDF]
388Hb HopeβD-10Dual Kit Program49.20.73[PDF]
392Hb AustinβD-10Dual Kit Program43.81.47[PDF]
396HbSβD-10Dual Kit Program26.44.09[PDF]
400HbSβD-10Dual Kit Program304.09heterozygote[PDF]
405Hb G-CopenhagenβD-10Dual Kit Program44.62.91[PDF]
409Hb G-San JoséβD-10Dual Kit Program314.17[PDF]
413HbCβD-10Dual Kit Program79.34.69[PDF]
417Hb Santa ClaraβD-10Dual Kit Program45.31.43[PDF]
421Hb D-PunjabβD-10Dual Kit Program293.81[PDF]
425Hb Hasharonα1D-10Dual Kit Program25.44.56[PDF]
429Hb Hasharonα1D-10Dual Kit Program29.14.56[PDF]
433HbEβD-10Dual Kit Program29.62.96heterozygote[PDF]
438Hb AbruzzoβD-10Dual Kit Program46.12.72[PDF]
441Hb G-San JoséβD-10Dual Kit Program28.54.18[PDF]
445Hb RomaβD-10Dual Kit Program28.54.18[PDF]
452Hb RandwickβD-10Dual Kit Program81.41.69[PDF]
458HbEβD-10Dual Kit Program19.92.96heterozygote[PDF]
462HbEβD-10Dual Kit Program28.82.92Association of HbE and Hb Constant Spring[PDF]
467HbSβD-10Dual Kit Program67.94.03heterozygote for HbS and B (o) thal [PDF]
470Hb ShelbyβD-10Dual Kit Program11.73.06[PDF]
473Hb ShelbyβD-10Dual Kit Program5.83.1heterozygote[PDF]
477Hb D-PunjabβD-10Dual Kit Program70.83.7double heterozygote Hb D-Punjab b thal[PDF]
482Hb VallettaβD-10Dual Kit Program66.31.74[PDF]
486Hb D-PunjabβD-10Dual Kit Program813.74[PDF]
488HbCβD-10Dual Kit Program29.64.7compounnd heterozygote for HbC and Hb Korle Bu[PDF]
490HbSβD-10Dual Kit Program31.44.07Compound heterozygote for HbC and HbS[PDF]
493Hb RandwickβD-10Dual Kit Program52.41.82Double heterozygote-Hb Randwick with Beta thalassemia[PDF]
496HbSβD-10Dual Kit Program39.54.22[PDF]
499HbSβD-10Dual Kit Program84.12[PDF]
503HbSβD-10Dual Kit Program54.44.07[PDF]
508HbSβD-10Dual Kit Program464.08Compound heterozygote for HbS and HbC[PDF]
509HbCβD-10Dual Kit Program46.44.7Compound heterozygote for HbS and HbC[PDF]
514HbSβD-10Dual Kit Program69.24.05Compound heterozygote for HbS and Beta (+) thal [PDF]
517HbSβD-10Dual Kit Program46.14.06Compound heterozygote for HbS and HbC[PDF]
518HbCβD-10Dual Kit Program46.34.07Compound heterozygote for HbS and HbC[PDF]
10HbSβD-10HbA1c Program401.65Heterozygous[PDF]
12HbSβD-10HbA1c Program81.21.65Homozygous[PDF]
18HbEβD-10HbA1c Program31.41.59Heterozygous[PDF]
20HbEβD-10HbA1c Program80.81.58Homozygous[PDF]
22Hb D-PunjabβD-10HbA1c Program41.51.63Heterozygous[PDF]
24Hb O-ArabβD-10HbA1c Program64.91.49Heterozygous[PDF]
30Hb D-PunjabβD-10HbA1c Program41.51.63[PDF]
32HbCβD-10HbA1c Program46.51.77Heterozygote[PDF]
34HbCβD-10HbA1c Program891.76Homozygote[PDF]
36HbSβD-10HbA1c Program38.21.77Compound heterozygote between HbS and HbC[PDF]
520HbCβD-10Dual Kit Program46.35.12Compound heterozygote for HbS and HbC[PDF]
523HbSβD-10Dual Kit Program58.94.06compound heterozygote for HbS and B (+) thalassemia[PDF]
527HbSβD-10Dual Kit Program44.44.07Compound heterozygote for HbS and HbC[PDF]
528HbCβD-10Dual Kit Program43.64.71Compound heterozygote for HbS and HbC[PDF]
535Hb D-PunjabβD-10Dual Kit Program37.93.74Compound heterozygote for HbS and Hb D-Punjab[PDF]
542HbCβD-10Dual Kit Program50.44.7HbC and (delta beta) O thal [PDF]
546HbCβD-10Dual Kit Program59.44.7heterozygote[PDF]
552Hb A2' or Hb B2δD-10Dual Kit Program1.54.19[PDF]
556Hb N-BaltimoreβD-10Dual Kit Program80.81.46[PDF]
559HbSβD-10Dual Kit Program30.74.08[PDF]
563Hb CamperdownβD-10Dual Kit Program46.70.68[PDF]
564HbEβD-10Dual Kit Program41.22.78[PDF]
568HbCβD-10Dual Kit Program48.14.79Cmpound heterozygote for HbC and Hb O-Arab[PDF]
569Hb O-ArabβD-10Dual Kit Program41.64.56compound heterozygote for HbC and Hb O-Arab[PDF]
576Hb Mexicoα1 or α2D-10Dual Kit Program27.31.37[PDF]
581HbIα1D-10Dual Kit Program10.41.36heterozygote[PDF]
585Hb Lepore-Boston-WashingtonδD-10Dual Kit Program4.82.69[PDF]
585Hb Lepore-Boston-WashingtonβD-10Dual Kit Program4.82.69[PDF]
589Hb M-Milwaukee-2βD-10Dual Kit Program31.64.71[PDF]
593Hb Lepore-Boston-WashingtonδD-10Dual Kit Program5.32.69[PDF]
593Hb Lepore-Boston-WashingtonβD-10Dual Kit Program5.32.69[PDF]
599Hb Aichiα1 or α2D-10Dual Kit Program21.94.05[PDF]
603Hb Setifα2D-10Dual Kit Program3.51.43heterozygote[PDF]
606Hb ProvidenceβD-10Dual Kit Program31.30.3[PDF]
607Hb ProvidenceβD-10Dual Kit Program16.40.97[PDF]
608Hb Setifα2D-10Dual Kit Program11.34.4[PDF]
2Hb I-Interlakenα1VARIANTβ-thal Short Program24.91.62Heterozygous[PDF]
7HbSβVARIANTβ-thal Short Program34.54.26Heterozygous[PDF]
15HbCβVARIANTβ-thal Short Program84.25.09Compound heterozygous with CD 39. Could be confused with HbC homozygous. A2 level and hematological data suggest an associated beta-thal.[PDF]
50Hb SiirtβVARIANTβ-thal Short Program82.32.5heterozygote[PDF]
67Hb DhofarβVARIANTβ-thal Short Program13.93.84[PDF]
71Hb Pierre-BéniteβVARIANTβ-thal Short Program84.82.33[PDF]
74Hb BicêtreβVARIANTβ-thal Short Program80.62.34[PDF]
78Hb M-SaskatoonβVARIANTβ-thal Short Program9.34.91[PDF]
86Hb J-BaltimoreβVARIANTβ-thal Short Program40.81.8[PDF]
90Hb AcharnesβVARIANTβ-thal Short Program30.22.28[PDF]
94Hb Chadα1 or α2VARIANTβ-thal Short Program25.24.89[PDF]
98Hb Roanneα1 or α2VARIANTβ-thal Short Program88.52.48heterozygote[PDF]
103Hb Toulonα2VARIANTβ-thal Short Program23.93.52heterozygote[PDF]
106Hb D-Ouled RabahβVARIANTβ-thal Short Program76.73.58[PDF]
110Hb Lyon-Bronα2VARIANTβ-thal Short Program30.71.73[PDF]
115Hb Saint-JacquesβVARIANTβ-thal Short Program79.22.5[PDF]
121Hb Gerlandα2VARIANTβ-thal Short Program87.52.46[PDF]
124Hb Henri MondorβVARIANTβ-thal Short Program35.72.92[PDF]
126Hb AubagneβVARIANTβ-thal Short Program85.22.47[PDF]
130Hb Stanleyville-IIα2VARIANTβ-thal Short Program29.94.18[PDF]
134Hb J-Sardegnaα2VARIANTβ-thal Short Program29.31.28[PDF]
138Hb Russα1VARIANTβ-thal Short Program15.74.18[PDF]
142Hb K WoolwichβVARIANTβ-thal Short Program35.21.29[PDF]
146Hb MaputoβVARIANTβ-thal Short Program40.93.72[PDF]
150Hb Brem-sur-MerβVARIANTβ-thal Short Program72.12.48[PDF]
154Hb Fannin-Lubbock IIβVARIANTβ-thal Short Program36.51.82[PDF]
158Hb Passyα2VARIANTβ-thal Short Program78.12.44[PDF]
160Hb Handsworthα1VARIANTβ-thal Short Program0.74.7[PDF]
162Hb Shimonosekiα1 or α2VARIANTβ-thal Short Program14.54.21[PDF]
166Hb Lombardα2VARIANTβ-thal Short Program872.45[PDF]
171Hb J-Tongarikiα1 or α2VARIANTβ-thal Short Program21.81.82[PDF]
175Hb D-IranβVARIANTβ-thal Short Program40.33.55compound heterozygote between HbS and Hb D-Iran[PDF]
179Hb YaoundeβVARIANTβ-thal Short Program76.52.46[PDF]
183Hb Dunnα1 or α2VARIANTβ-thal Short Program13.23.95heterozygote[PDF]
187Hb J-Tongarikiα1 or α2VARIANTβ-thal Short Program19.31.78[PDF]
191Hb Chicagoα2VARIANTβ-thal Short Program842.47[PDF]
196Hb HikariβVARIANTβ-thal Short Program35.32.04[PDF]
200Hb G-SzuhuβVARIANTβ-thal Short Program37.74.54[PDF]
204Hb Ambroise Pareα2VARIANTβ-thal Short Program81.52.44[PDF]
208Hb Groene Hartα1VARIANTβ-thal Short Program81.92.46[PDF]
212Hb Q-Thailandα1VARIANTβ-thal Short Program22.94.51heterozygote[PDF]
215Hb D-PunjabβVARIANTβ-thal Short Program80.74.05[PDF]
217Hb Milledgevilleα1 or α2VARIANTβ-thal Short Program18.42.19[PDF]
221Hb Nunobikiα1 or α2VARIANTβ-thal Short Program12.81.51[PDF]
225Hb Summer HillβVARIANTβ-thal Short Program38.44.24heterozygote[PDF]
227Hb Fort de Franceα1 or α2VARIANTβ-thal Short Program16.33.52heterozygote[PDF]
229Hb J-Broussaisα1 or α2VARIANTβ-thal Short Program24.81.62[PDF]
231HbSβVARIANTβ-thal Short Program38.44.24[PDF]
234Hb K-IbadanβVARIANTβ-thal Short Program321.99heterozygote[PDF]
238HbSβVARIANTβ-thal Short Program90.44.26[PDF]
242HbSβVARIANTβ-thal Short Program74.54.26[PDF]
248HbSβVARIANTβ-thal Short Program22.44.25[PDF]
255Hb G-Philadelphiaα1 or α2VARIANTβ-thal Short Program26.74.01[PDF]
259HbCβVARIANTβ-thal Short Program23.85.03[PDF]
263HbSβVARIANTβ-thal Short Program80.84.38[PDF]
266HbCβVARIANTβ-thal Short Program37.64heterozygote[PDF]
270Hb D-IranβVARIANTβ-thal Short Program383.56heterzygote[PDF]
274Hb Hasharonα1VARIANTβ-thal Short Program19.54.74heterozygote[PDF]
278Hb Hopkins-IIα1 or α2VARIANTβ-thal Short Program19.31.5heterozygote[PDF]
282Hb J-BangkokβVARIANTβ-thal Short Program38.71.9heterozygote[PDF]
286Hb J-Broussaisα1 or α2VARIANTβ-thal Short Program27.81.62heterozygote[PDF]
290Hb J-Paris-Iα1VARIANTβ-thal Short Program26.31.7heterozygote[PDF]
294Hb J-Sardegnaα2VARIANTβ-thal Short Program34.81.18heterozygote[PDF]
298Hb Le Lamentinα2VARIANTβ-thal Short Program25.41.51heterozygote[PDF]
302Hb O-ArabβVARIANTβ-thal Short Program32.94.38heterozygote[PDF]
306Hb O-Padovaα1 or α2VARIANTβ-thal Short Program15.34.73heterozygote[PDF]
310Hb Q-Indiaα1VARIANTβ-thal Short Program17.34.7heterozygote[PDF]
314HbSβVARIANTβ-thal Short Program36.44.31[PDF]
318Hb D-IbadanβVARIANTβ-thal Short Program39.13.85[PDF]
322Hb VallettaβVARIANTβ-thal Short Program872.46[PDF]
332Hb Sunshine Sethα2VARIANTβ-thal Short Program18.84.71heterozygote[PDF]
336HbEβVARIANTβ-thal Short Program76.43.65[PDF]
340Hb TacomaβVARIANTβ-thal Short Program72.12.41[PDF]
344Hb Old Dominion/Burton-upon-Trent (OD/BuT)βVARIANTβ-thal Short Program32.61.85heterozygote[PDF]
348Hb Hopkins-IIα1 or α2VARIANTβ-thal Short Program12.51.46[PDF]
352Hb G-Philadelphiaα1 or α2VARIANTβ-thal Short Program21.74.04heterozygote[PDF]
358Hb Goudaα2VARIANTβ-thal Short Program30.91.64heterozygote[PDF]
362HbCβVARIANTβ-thal Short Program79.45.06[PDF]
366Hb Le Lamentinα2VARIANTβ-thal Short Program331.49heterozygote[PDF]
370Hb J-Meerutα2VARIANTβ-thal Short Program17.61.86heterozygote[PDF]
374Hb Winnipegα1VARIANTβ-thal Short Program18.84.74[PDF]
377Hb Seal Rockα2VARIANTβ-thal Short Program1.94.7[PDF]
381Hb D-PunjabβVARIANTβ-thal Short Program37.44.08heterozygote[PDF]
385Hb G-AccraβVARIANTβ-thal Short Program43.94.88[PDF]
389Hb HopeβVARIANTβ-thal Short Program47.31.36[PDF]
393Hb AustinβVARIANTβ-thal Short Program45.61.64[PDF]
397HbSβVARIANTβ-thal Short Program28.24.3[PDF]
401HbSβVARIANTβ-thal Short Program324.33heterozygote[PDF]
404Hb N-BaltimoreβVARIANTβ-thal Short Program83.71.65[PDF]
406Hb G-CopenhagenβVARIANTβ-thal Short Program40.63.74[PDF]
410Hb G-San JoséβVARIANTβ-thal Short Program34.54.54[PDF]
414HbCβVARIANTβ-thal Short Program82.35.06[PDF]
418Hb Santa ClaraβVARIANTβ-thal Short Program46.71.65[PDF]
422Hb D-PunjabβVARIANTβ-thal Short Program283.99[PDF]
426Hb Hasharonα1VARIANTβ-thal Short Program25.74.74[PDF]
430Hb Hasharonα1VARIANTβ-thal Short Program27.94.74[PDF]
434HbEβVARIANTβ-thal Short Program253.63heterozygote[PDF]
442Hb G-San JoséβVARIANTβ-thal Short Program31.34.52[PDF]
446Hb RomaβVARIANTβ-thal Short Program31.34.52[PDF]
449Hb CamperdownβVARIANTβ-thal Short Program45.91.29[PDF]
453Hb RandwickβVARIANTβ-thal Short Program82.62.38[PDF]
459HbEβVARIANTβ-thal Short Program17.73.64heterozygote[PDF]
463HbEβVARIANTβ-thal Short Program25.33.68Association of HbE and Hb Constant Spring[PDF]
471Hb ShelbyβVARIANTβ-thal Short Program10.63.61[PDF]
474Hb ShelbyβVARIANTβ-thal Short Program3.93.62heterozygote[PDF]
478Hb D-PunjabβVARIANTβ-thal Short Program73.74.01heterozygote Hb D-Punjab / B thal[PDF]
483Hb VallettaβVARIANTβ-thal Short Program66.42.58[PDF]
489HbCβVARIANTβ-thal Short Program325.1compound heterozygote for HbC and Hb Korle Bu[PDF]
491HbSβVARIANTβ-thal Short Program31.44.37compound heterozygote for HbC and HbS[PDF]
492HbCβVARIANTβ-thal Short Program29.95.11Compound heterozygote dor HbC and HbS[PDF]
494Hb RandwickβVARIANTβ-thal Short Program67.72.64double heterozygote-Hb Randwick with Beta thalassemia[PDF]
500HbSβVARIANTβ-thal Short Program124.22[PDF]
504HbSβVARIANTβ-thal Short Program62.84.26[PDF]
5Hb I-Interlakenα1VARIANT IIDual Kit Program24.31.56Heterozygous
9HbSβVARIANT IIDual Kit Program33.73.47Heterozygous[PDF]
17HbCβVARIANT IIDual Kit Program82.34.42Compound heterozygous with CD 39. Could be confused with HbC homozygous. A2 level and hematological data suggest an associated beta-thal.[PDF]
38HbEβVARIANT IIDual Kit Program27.63.65[PDF]
39HbEβVARIANT IIDual Kit Program22.42.969[PDF]
44Hb ShelbyβVARIANT IIDual Kit Program10.73.65[PDF]
47HbSβVARIANT IIDual Kit Program23.84.46heterozygote[PDF]
48HbSβVARIANT IIDual Kit Program21.33.49heterozygote[PDF]
51Hb SiirtβVARIANT IIDual Kit Program80.31.76heterozygote[PDF]
53Hb G-Honoluluα1 or α2VARIANT IIDual Kit Program21.13.8[PDF]
54Hb G-Honoluluα1 or α2VARIANT IIDual Kit Program20.23.18
57Hb St. Claudeα1 or α2VARIANT IIDual Kit Program22.11.49[PDF]
60Hb G-CoushattaβVARIANT IIDual Kit Program61.12.69homozygote
63Hb CamdenβVARIANT IIDual Kit Program50.30.87[PDF]
69Hb DhofarβVARIANT IIDual Kit Program18.93.12[PDF]
72Hb Pierre-BéniteβVARIANT IIDual Kit Program83.21.753[PDF]
76Hb BicêtreβVARIANT IIDual Kit Program83.81.8[PDF]
80Hb M-SaskatoonβVARIANT IIDual Kit Program4.44.51[PDF]
84Hb RainierβVARIANT IIDual Kit Program72.21.77[PDF]
88Hb J-BaltimoreβVARIANT IIDual Kit Program43.91.567[PDF]
92Hb AcharnesβVARIANT IIDual Kit Program80.11.776[PDF]
96Hb Chadα1 or α2VARIANT IIDual Kit Program20.64.115[PDF]
100Hb Roanneα1 or α2VARIANT IIDual Kit Program87.91.76heterozygote[PDF]
108Hb D-Ouled RabahβVARIANT IIDual Kit Program59.22.736[PDF]
113Hb Lyon-Bronα2VARIANT IIDual Kit Program29.91.502[PDF]
117Hb Saint-JacquesβVARIANT IIDual Kit Program29.62.316[PDF]
119Hb HamiltonβVARIANT IIDual Kit Program861.789[PDF]
123Hb Gerlandα2VARIANT IIDual Kit Program8.12.609[PDF]
128Hb AubagneβVARIANT IIDual Kit Program85.61.801[PDF]
132Hb Stanleyville-IIα2VARIANT IIDual Kit Program32.13.401[PDF]
136Hb J-Sardegnaα2VARIANT IIDual Kit Program25.40.676[PDF]
140Hb Russα1VARIANT IIDual Kit Program163.483[PDF]
144Hb K WoolwichβVARIANT IIDual Kit Program37.20.859[PDF]
148Hb MaputoβVARIANT IIDual Kit Program40.12.98[PDF]
152Hb Brem-sur-MerβVARIANT IIDual Kit Program1.53.027[PDF]
156Hb Fannin-Lubbock IIβVARIANT IIDual Kit Program36.51.66[PDF]
164Hb MalmöβVARIANT IIDual Kit Program46.21.427[PDF]
169Hb Lombardα2VARIANT IIDual Kit Program87.91.809[PDF]
173Hb J-Tongarikiα1 or α2VARIANT IIDual Kit Program21.61.684[PDF]
177Hb D-IranβVARIANT IIDual Kit Program40.32.823compound heterozygote between HbS and Hb D-Iran[PDF]
181Hb YaoundeβVARIANT IIDual Kit Program73.21.822[PDF]
185Hb Dunnα1 or α2VARIANT IIDual Kit Program13.43.257heterozygote[PDF]
189Hb J-Torontoα1 or α2VARIANT IIDual Kit Program201.693[PDF]
193Hb Chicagoα2VARIANT IIDual Kit Program82.31.767[PDF]
194Hb Chicagoα2VARIANT IIDual Kit Program82.31.767[PDF]
198Hb HikariβVARIANT IIDual Kit Program31.51.753[PDF]
202Hb G-SzuhuβVARIANT IIDual Kit Program3.23.017[PDF]
206Hb Ambroise Pareα2VARIANT IIDual Kit Program80.71.797[PDF]
210Hb Groene Hartα1VARIANT IIDual Kit Program801.772[PDF]
214Hb Q-Thailandα1VARIANT IIDual Kit Program23.83.644heterozygote[PDF]
219Hb Milledgevilleα1 or α2VARIANT IIDual Kit Program84.11.82[PDF]
507HbSβVARIANTβ-thal Short Program79.74.37[PDF]
510HbSβVARIANTβ-thal Short Program45.14.35Compound heterozygote for HbS and HbC[PDF]
511HbCβVARIANTβ-thal Short Program45.85.1Compound heterozygote for HbC and HbS[PDF]
515HbSβVARIANTβ-thal Short Program74.64.38Compound heterozygote for HbS and Beta (+) thal[PDF]
519HbSβVARIANTβ-thal Short Program45.84.37Compound heterozygote for HbS and HbC[PDF]
524HbSβVARIANTβ-thal Short Program64.24.32Compound heterozygote for HbS and B (+) thalassemia[PDF]
529HbSβVARIANTβ-thal Short Program44.74.36Compound heterozygote for HbS and HbC[PDF]
530HbCβVARIANTβ-thal Short Program45.95.11Compound heterozygote for HbS and HbC[PDF]
536Hb D-PunjabβVARIANTβ-thal Short Program40.74compound heterozygote for HbS and Hb D-Punjab[PDF]
537HbSβVARIANTβ-thal Short Program40.24.3Compound heterozygote for HbS and Hb D-Punjab[PDF]
543HbCβVARIANTβ-thal Short Program61.15.1HbC and (delta-beta) O thal[PDF]
547HbCβVARIANTβ-thal Short Program625.1heterozygote[PDF]
553Hb A2' or Hb B2δVARIANTβ-thal Short Program1.54.47[PDF]
560HbSβVARIANTβ-thal Short Program31.64.35[PDF]
565HbEβVARIANTβ-thal Short Program473.73[PDF]
570HbCβVARIANTβ-thal Short Program47.75.12Compound heterozygote for HbC and Hb O-Arab[PDF]
571Hb O-ArabβVARIANTβ-thal Short Program44.84.85compound heterozygote for HbC and Hb O-Arab[PDF]
577Hb Mexicoα1 or α2VARIANTβ-thal Short Program27.81.75[PDF]
582HbIα1VARIANTβ-thal Short Program14.81.39heterozygote[PDF]
586Hb Lepore-Boston-WashingtonδVARIANTβ-thal Short Program10.53.5[PDF]
586Hb Lepore-Boston-WashingtonβVARIANTβ-thal Short Program10.53.5[PDF]
590Hb M-Milwaukee-2βVARIANTβ-thal Short Program34.95.08[PDF]
594Hb Lepore-Boston-WashingtonδVARIANTβ-thal Short Program9.73.42[PDF]
594Hb Lepore-Boston-WashingtonβVARIANTβ-thal Short Program9.73.42[PDF]
600Hb Aichiα1 or α2VARIANTβ-thal Short Program19.74.17[PDF]
604Hb Setifα2VARIANTβ-thal Short Program3.51.6heterozygote[PDF]
609Hb Setifα2VARIANTβ-thal Short Program14.54.66[PDF]
4Hb I-Interlakenα1VARIANT IIβ-thal Short Program24.81.63Heterozygous[PDF]
8HbSβVARIANT IIβ-thal Short Program34.64.4Heterozygous[PDF]
16HbCβVARIANT IIβ-thal Short Program86.85.16Compound heterozygous with CD 39. Could be confused with HbC homozygous. A2 level and hematological data suggest an associated beta-thal.[PDF]
28HbSβVARIANT IIβ-thal Short Program69.44.41Compound heterozygote for HbS and HPFH[PDF]
37HbEβVARIANT IIβ-thal Short Program25.13.66[PDF]
43HbSβVARIANT IIβ-thal Short Program77.24.3compoud heterozygote between HbS and B (o) thal[PDF]
46HbSβVARIANT IIβ-thal Short Program22.94.35heterozygote[PDF]
56Hb St. Claudeα1 or α2VARIANT IIβ-thal Short Program22.41.88[PDF]
59Hb G-CoushattaβVARIANT IIβ-thal Short Program75.13.48homozygote[PDF]
62Hb CamdenβVARIANT IIβ-thal Short Program44.51.36[PDF]
68Hb DhofarβVARIANT IIβ-thal Short Program12.83.92[PDF]
75Hb BicêtreβVARIANT IIβ-thal Short Program85.22.5[PDF]
79Hb M-SaskatoonβVARIANT IIβ-thal Short Program11.75[PDF]
82Hb RainierβVARIANT IIβ-thal Short Program78.12.48[PDF]
83Hb RainierβVARIANT IIβ-thal Short Program78.32.51[PDF]
87Hb J-BaltimoreβVARIANT IIβ-thal Short Program44.81.83[PDF]
91Hb AcharnesβVARIANT IIβ-thal Short Program82.82.47[PDF]
95Hb Chadα1 or α2VARIANT IIβ-thal Short Program23.64.96[PDF]
99Hb Roanneα1 or α2VARIANT IIβ-thal Short Program89.12.43heterozygote[PDF]
104Hb Toulonα2VARIANT IIβ-thal Short Program253.57heterozygote[PDF]
107Hb D-Ouled RabahβVARIANT IIβ-thal Short Program75.13.57[PDF]
111Hb Lyon-Bronα2VARIANT IIβ-thal Short Program30.11.82[PDF]
116Hb Saint-JacquesβVARIANT IIβ-thal Short Program80.52.56[PDF]
118Hb HamiltonβVARIANT IIβ-thal Short Program87.42.55[PDF]
122Hb Gerlandα2VARIANT IIβ-thal Short Program87.62.47
127Hb AubagneβVARIANT IIβ-thal Short Program86.22.55[PDF]
131Hb Stanleyville-IIα2VARIANT IIβ-thal Short Program29.74.31[PDF]
135Hb J-Sardegnaα2VARIANT IIβ-thal Short Program30.31.24[PDF]
139Hb Russα1VARIANT IIβ-thal Short Program15.14.32[PDF]
143Hb K WoolwichβVARIANT IIβ-thal Short Program34.41.29[PDF]
147Hb MaputoβVARIANT IIβ-thal Short Program39.63.74[PDF]
151Hb Brem-sur-MerβVARIANT IIβ-thal Short Program76.52.58[PDF]
155Hb Fannin-Lubbock IIβVARIANT IIβ-thal Short Program36.11.91[PDF]
163Hb MalmöβVARIANT IIβ-thal Short Program18.31.7[PDF]
167Hb Lombardα2VARIANT IIβ-thal Short Program88.82.55[PDF]
172Hb J-Tongarikiα1 or α2VARIANT IIβ-thal Short Program22.61.91[PDF]
176Hb D-IranβVARIANT IIβ-thal Short Program40.43.56compound heterozygote between HbS and Hb D-Iran[PDF]
180Hb YaoundeβVARIANT IIβ-thal Short Program75.22.55[PDF]
184Hb Dunnα1 or α2VARIANT IIβ-thal Short Program12.64.01heterozygote[PDF]
188Hb J-Torontoα1 or α2VARIANT IIβ-thal Short Program22.41.88[PDF]
192Hb Chicagoα2VARIANT IIβ-thal Short Program852.5[PDF]
197Hb HikariβVARIANT IIβ-thal Short Program34.52.13[PDF]
201Hb G-SzuhuβVARIANT IIβ-thal Short Program34.52.13[PDF]
205Hb Ambroise Pareα2VARIANT IIβ-thal Short Program83.32.5[PDF]
209Hb Groene Hartα1VARIANT IIβ-thal Short Program82.42.5[PDF]
213Hb Q-Thailandα1VARIANT IIβ-thal Short Program86.94.38heterozygote[PDF]
218Hb Milledgevilleα1 or α2VARIANT IIβ-thal Short Program22.32.26[PDF]
40HbCβVARIANT IIDual Kit Program - HbA1c41.72.04heterozygote[PDF]
41Hb D-PunjabβVARIANT IIDual Kit Program - HbA1c42.21.83heterozygote[PDF]
42HbSβVARIANT IIDual Kit Program - HbA1c44.71.88heterozygote[PDF]
64HbEβVARIANT IIDual Kit Program - HbA1c85.91.737homozygote[PDF]
11HbSβVARIANT IIHbA1c Program39.21.94[PDF]
13HbSβVARIANT IIHbA1c Program84.41.93Homozygous[PDF]
19HbEβVARIANT IIHbA1c Program30.31.86Heterozygous[PDF]
21HbEβVARIANT IIHbA1c Program80.11.84Homozygous[PDF]
23Hb D-PunjabβVARIANT IIHbA1c Program401.9Heterozygous[PDF]
25Hb O-ArabβVARIANT IIHbA1c Program31.32.02Heterozygous[PDF]
29HbSβVARIANT IIHbA1c Program39.21.94Heterozygote[PDF]
31Hb D-PunjabβVARIANT IIHbA1c Program401.9Heterozygote[PDF]
33HbCβVARIANT IIHbA1c Program37.12.11Heterozygote[PDF]
35HbCβVARIANT IIHbA1c Program972.1Homozygote[PDF]
223Hb Nunobikiα1 or α2VARIANT IIDual Kit Program61.55[PDF]
235Hb RandwickβVARIANT IIDual Kit Program61.22.98heterozygote[PDF]
240HbSβVARIANT IIDual Kit Program86.63.44[PDF]
244HbSβVARIANT IIDual Kit Program68.93[PDF]
245HbSβVARIANT IIDual Kit Program68.93[PDF]
246HbSβVARIANT IIDual Kit Program68.93.45[PDF]
250HbSβVARIANT IIDual Kit Program24.13.49[PDF]
253HbSβVARIANT IIDual Kit Program77.93.48[PDF]
257Hb G-Philadelphiaα1 or α2VARIANT IIDual Kit Program28.93.35[PDF]
261HbCβVARIANT IIDual Kit Program24.94.438[PDF]
264HbSβVARIANT IIDual Kit Program73.73.387[PDF]
268HbCβVARIANT IIDual Kit Program32.24.433heterozygote[PDF]
272Hb D-IranβVARIANT IIDual Kit Program392.71heterozygote[PDF]
276Hb Hasharonα1VARIANT IIDual Kit Program19.24.19heterozygote[PDF]
280Hb Hopkins-IIα1 or α2VARIANT IIDual Kit Program19.51.5heterozygote[PDF]
284Hb J-BangkokβVARIANT IIDual Kit Program32.31.66heterozygote[PDF]
288Hb J-Broussaisα1 or α2VARIANT IIDual Kit Program12.21.48heterozygote[PDF]
292Hb J-Paris-Iα1VARIANT IIDual Kit Program25.51.59heterozygote
296Hb J-Paris-Iα2VARIANT IIDual Kit Program350.55heterozygote[PDF]
300Hb Le Lamentinα2VARIANT IIDual Kit Program25.51.41heterozygote[PDF]
304Hb O-ArabβVARIANT IIDual Kit Program30.64.01heterozygote[PDF]
308Hb O-Padovaα1 or α2VARIANT IIDual Kit Program14.53.93heterozygote[PDF]
312Hb Q-Indiaα1VARIANT IIDual Kit Program14.93.93heterozygote[PDF]
316HbSβVARIANT IIDual Kit Program33.33.47[PDF]
320Hb D-IbadanβVARIANT IIDual Kit Program35.83.17[PDF]
324Hb VallettaβVARIANT IIDual Kit Program81.61.75[PDF]
330Hb St. Luke'sα1VARIANT IIDual Kit Program8.83.68[PDF]
334Hb Sunshine Sethα2VARIANT IIDual Kit Program15.23.956heterozygote[PDF]
338HbEβVARIANT IIDual Kit Program69.42.9[PDF]
342Hb TacomaβVARIANT IIDual Kit Program67.11.77[PDF]
346Hb Old Dominion/Burton-upon-Trent (OD/BuT)βVARIANT IIDual Kit Program38.91.58heterozygote[PDF]
350Hb Hopkins-IIα1 or α2VARIANT IIDual Kit Program22.61.49[PDF]
354Hb G-Philadelphiaα1 or α2VARIANT IIDual Kit Program233.37heterozygote[PDF]
356Hb J-BangkokβVARIANT IIDual Kit Program26.41.7[PDF]
360Hb Q-Iranα1 or α2VARIANT IIDual Kit Program19.24.09heterozygote[PDF]
364HbCβVARIANT IIDual Kit Program74.84.41[PDF]
368Hb Le Lamentinα2VARIANT IIDual Kit Program29.11.47heterozygote[PDF]
372Hb J-Meerutα2VARIANT IIDual Kit Program9.51.53heterozygote[PDF]
375Hb Winnipegα1VARIANT IIDual Kit Program16.14.084[PDF]
379Hb Seal Rockα2VARIANT IIDual Kit Program0.74.104[PDF]
383Hb D-PunjabβVARIANT IIDual Kit Program38.53.233heterozygote[PDF]
387Hb G-AccraβVARIANT IIDual Kit Program43.13.144[PDF]
391Hb HopeβVARIANT IIDual Kit Program47.80.921[PDF]
395Hb AustinβVARIANT IIDual Kit Program441.592[PDF]
399HbSβVARIANT IIDual Kit Program27.13.487[PDF]
403HbSβVARIANT IIDual Kit Program30.53.499heterozygote[PDF]
408Hb G-CopenhagenβVARIANT IIDual Kit Program38.82.896[PDF]
412Hb G-San JoséβVARIANT IIDual Kit Program32.93.564[PDF]
416HbCβVARIANT IIDual Kit Program78.94.416[PDF]
420Hb Santa ClaraβVARIANT IIDual Kit Program45.61.522[PDF]
424Hb D-PunjabβVARIANT IIDual Kit Program30.63.276[PDF]
428Hb Hasharonα1VARIANT IIDual Kit Program25.94.205[PDF]
432Hb Hasharonα1VARIANT IIDual Kit Program274.207[PDF]
436HbEβVARIANT IIDual Kit Program25.92.926heterozygote[PDF]
440Hb AbruzzoβVARIANT IIDual Kit Program38.82.836[PDF]
444Hb G-San JoséβVARIANT IIDual Kit Program31.33.623[PDF]
448Hb RomaβVARIANT IIDual Kit Program31.33.623[PDF]
451Hb CamperdownβVARIANT IIDual Kit Program45.50.958[PDF]
455Hb RandwickβVARIANT IIDual Kit Program2.92.995[PDF]
461HbEβVARIANT IIDual Kit Program18.92.91heterozygote[PDF]
465HbEβVARIANT IIDual Kit Program27.22.899Association of HbE and Hb Constant Spring[PDF]
469HbSβVARIANT IIDual Kit Program68.53.437compound heterozygote for HbS and B (o) thal [PDF]
472Hb ShelbyβVARIANT IIDual Kit Program12.22.968[PDF]
476Hb ShelbyβVARIANT IIDual Kit Program3.92.979heterozygote[PDF]
480Hb D-PunjabβVARIANT IIDual Kit Program75.43.191heterozygote Hb D-Punjab / B thal[PDF]
485Hb VallettaβVARIANT IIDual Kit Program61.21.886[PDF]
487Hb D-PunjabβVARIANT IIDual Kit Program84.83.212[PDF]
498HbSβVARIANT IIDual Kit Program38.63.472[PDF]
502HbSβVARIANT IIDual Kit Program6.93.545[PDF]
222Hb Nunobikiα1 or α2VARIANT IIβ-thal Short Program12.71.6[PDF]
239HbSβVARIANT IIβ-thal Short Program91.14.45[PDF]
243HbSβVARIANT IIβ-thal Short Program75.34.43[PDF]
249HbSβVARIANT IIβ-thal Short Program25.34.43[PDF]
252HbSβVARIANT IIβ-thal Short Program79.84.47[PDF]
256Hb G-Philadelphiaα1 or α2VARIANT IIβ-thal Short Program294.12[PDF]
260HbCβVARIANT IIβ-thal Short Program25.15.11[PDF]
267HbCβVARIANT IIβ-thal Short Program33.95.17heterozygote[PDF]
271Hb D-IranβVARIANT IIβ-thal Short Program38.73.54heterozygote[PDF]
275Hb Hasharonα1VARIANT IIβ-thal Short Program204.82heterozygote[PDF]
279Hb Hopkins-IIα1 or α2VARIANT IIβ-thal Short Program191.51heterozygote[PDF]
283Hb J-BangkokβVARIANT IIβ-thal Short Program38.71.92heterozygote[PDF]
287Hb J-Broussaisα1 or α2VARIANT IIβ-thal Short Program28.11.65heterozygote[PDF]
291Hb J-Paris-Iα1VARIANT IIβ-thal Short Program26.21.71heterozygote[PDF]
295Hb J-Sardegnaα2VARIANT IIβ-thal Short Program34.31.19heterozygote[PDF]
299Hb Le Lamentinα2VARIANT IIβ-thal Short Program25.61.49heterozygote[PDF]
303Hb O-ArabβVARIANT IIβ-thal Short Program32.34.91heterozygote[PDF]
307Hb O-Padovaα1 or α2VARIANT IIβ-thal Short Program16.74.79heterozygote[PDF]
311Hb Q-Indiaα1VARIANT IIβ-thal Short Program17.24.79heterozygote[PDF]
315HbSβVARIANT IIβ-thal Short Program36.94.43[PDF]
319Hb D-IbadanβVARIANT IIβ-thal Short Program39.13.94[PDF]
323Hb VallettaβVARIANT IIβ-thal Short Program85.82.39[PDF]
325Hb F-Malta-IVARIANT IIβ-thal Short Program49.71.16[PDF]
326Hb F-Malta-IVARIANT IIβ-thal Short Program53.31.17[PDF]
328Hb St. Luke'sα1VARIANT IIβ-thal Short Program9.44.46[PDF]
329Hb St. Luke'sα1VARIANT IIβ-thal Short Program8.84.58[PDF]
333Hb Sunshine Sethα2VARIANT IIβ-thal Short Program164.79heterozygote[PDF]
337HbEβVARIANT IIβ-thal Short Program69.53.64[PDF]
341Hb TacomaβVARIANT IIβ-thal Short Program71.42.41[PDF]
345Hb Old Dominion/Burton-upon-Trent (OD/BuT)βVARIANT IIβ-thal Short Program33.21.88heterozygote[PDF]
349Hb Hopkins-IIα1 or α2VARIANT IIβ-thal Short Program10.31.6[PDF]
353Hb G-Philadelphiaα1 or α2VARIANT IIβ-thal Short Program21.54.13heterozygote[PDF]
355Hb J-BangkokβVARIANT IIβ-thal Short Program34.52.02[PDF]
359Hb Q-Iranα1 or α2VARIANT IIβ-thal Short Program21.24.85heterozygote[PDF]
363HbCβVARIANT IIβ-thal Short Program18.54.86[PDF]
367Hb Le Lamentinα2VARIANT IIβ-thal Short Program5.61.66heterozygote[PDF]
371Hb J-Meerutα2VARIANT IIβ-thal Short Program7.41.65heterozygote[PDF]
378Hb Seal Rockα2VARIANT IIβ-thal Short Program0.94.77[PDF]
382Hb D-PunjabβVARIANT IIβ-thal Short Program37.34.14heterozygote[PDF]
386Hb G-AccraβVARIANT IIβ-thal Short Program43.53.89[PDF]
390Hb HopeβVARIANT IIβ-thal Short Program47.81.4[PDF]
394Hb AustinβVARIANT IIβ-thal Short Program45.81.75[PDF]
398HbSβVARIANT IIβ-thal Short Program27.54.43[PDF]
402HbSβVARIANT IIβ-thal Short Program31.94.44heterozygote[PDF]
407Hb G-CopenhagenβVARIANT IIβ-thal Short Program39.23.75[PDF]
411Hb G-San JoséβVARIANT IIβ-thal Short Program36.64.6[PDF]
415HbCβVARIANT IIβ-thal Short Program85.45.13[PDF]
419Hb Santa ClaraβVARIANT IIβ-thal Short Program45.91.66[PDF]
423Hb D-PunjabβVARIANT IIβ-thal Short Program28.84.08[PDF]
427Hb Hasharonα1VARIANT IIβ-thal Short Program27.14.82[PDF]
435HbEβVARIANT IIβ-thal Short Program25.13.65heterozygote[PDF]
439Hb AbruzzoβVARIANT IIβ-thal Short Program423.39[PDF]
443Hb G-San JoséβVARIANT IIβ-thal Short Program33.34.6[PDF]
447Hb RomaβVARIANT IIβ-thal Short Program3.334.6[PDF]
450Hb CamperdownβVARIANT IIβ-thal Short Program43.11.34[PDF]
454Hb RandwickβVARIANT IIβ-thal Short Program81.82.41[PDF]
460HbEβVARIANT IIβ-thal Short Program19.43.68heterozygote[PDF]
464HbEβVARIANT IIβ-thal Short Program27.13.68Association of HbE and Hb Constant Spring[PDF]
468HbSβVARIANT IIβ-thal Short Program77.54.43heterozygote for HbS and B (o) thal[PDF]
475Hb ShelbyβVARIANT IIβ-thal Short Program4.43.66heterozygote[PDF]
479Hb D-PunjabβVARIANT IIβ-thal Short Program77.84.08heterozygote Hb D-Punjab / B thal [PDF]
481Hb SiirtβVARIANT IIβ-thal Short Program82.92.54[PDF]
484Hb VallettaβVARIANT IIβ-thal Short Program66.12.65[PDF]
495Hb RandwickβVARIANT IIβ-thal Short Program66.82.66Double heterozygote - Hb Randwick with Beta thalassemia[PDF]
497HbSβVARIANT IIβ-thal Short Program53.54.46[PDF]
501HbSβVARIANT IIβ-thal Short Program11.84.36[PDF]
505HbSβVARIANT IIβ-thal Short Program64.14.45[PDF]
456HbSβVARIANT IIDual Kit Program - HbA1c44.92.035Compound heterozygote between HbS and HbC[PDF]
457HbSβVARIANT IIDual Kit Program - HbA1c85.61.87[PDF]
466HbSβVARIANT IIHbA1c Program52.11.94Compound heterozygote between HbS and HbC[PDF]
506HbSβVARIANT IIDual Kit Program53.63.465[PDF]
512HbSβVARIANT IIDual Kit Program45.73.427Compound heterozygote for HbS and HbC[PDF]
513HbCβVARIANT IIDual Kit Program42.74.422Compound heterozygote for HbC and HbS[PDF]
516HbSβVARIANT IIDual Kit Program70.63.402compound heterozygote for HbS and Beta (+) thal[PDF]
521HbSβVARIANT IIDual Kit Program46.73.429Compound heterozygote for HbS and HbC[PDF]
522HbCβVARIANT IIDual Kit Program43.24.431compound heterozygote for HbS and HbC[PDF]
526HbSβVARIANT IIDual Kit Program59.53.432compound heterozygote for HbS and B (+) thalassemia[PDF]
533HbSβVARIANT IIDual Kit Program44.63.44compound heterozygote for HbS and HbC[PDF]
534HbCβVARIANT IIDual Kit Program40.84.423Compound heterozygote for HbS and HbC[PDF]
540Hb D-PunjabβVARIANT IIDual Kit Program403.21Compound heterozygote for HbS and Hb D-Punjab[PDF]
541HbSβVARIANT IIDual Kit Program37.53.455compound heterozygote for HbS and Hb D-Punjab[PDF]
545HbCβVARIANT IIDual Kit Program504.414HbC and (delta-beta) O thal [PDF]
549HbCβVARIANT IIDual Kit Program59.34.422heterozygote[PDF]
551Hb Goudaα2VARIANT IIDual Kit Program33.31.557heterozygote[PDF]
555Hb A2' or Hb B2δVARIANT IIDual Kit Program0.83.62[PDF]
558Hb N-BaltimoreβVARIANT IIDual Kit Program791.535[PDF]
562HbSβVARIANT IIDual Kit Program31.13.452[PDF]
567HbEβVARIANT IIDual Kit Program42.62.885[PDF]
574HbCβVARIANT IIDual Kit Program43.84.419Compound heterozygote for HbC and Hb O-Arab[PDF]
575Hb O-ArabβVARIANT IIDual Kit Program42.13.999Compound heterozygote for HbC and Hb O-Arab[PDF]
580Hb Mexicoα1 or α2VARIANT IIDual Kit Program28.11.49[PDF]
584HbIα1VARIANT IIDual Kit Program22.51.467heterozygote[PDF]
588Hb Lepore-Boston-WashingtonδVARIANT IIDual Kit Program13.12.827[PDF]
588Hb Lepore-Boston-WashingtonβVARIANT IIDual Kit Program13.12.827[PDF]
592Hb M-Milwaukee-2βVARIANT IIDual Kit Program31.14.435[PDF]
596Hb Lepore-Boston-WashingtonδVARIANT IIDual Kit Program10.82.887[PDF]
596Hb Lepore-Boston-WashingtonβVARIANT IIDual Kit Program10.82.887[PDF]
598HbIα1VARIANT IIDual Kit Program27.91.491[PDF]
602Hb Aichiα1 or α2VARIANT IIDual Kit Program22.53.465[PDF]
605Hb Setifα2VARIANT IIDual Kit Program61.529heterozygote[PDF]
611Hb Setifα2VARIANT IIDual Kit Program10.43.908[PDF]
614HbSβVARIANT IIDual Kit Program28.83.489[PDF]
615Hb Montgomeryα2VARIANT IIDual Kit Program6.54.425[PDF]
525HbSβVARIANT IIβ-thal Short Program664.44Compound heterozygote for HbS and B (+) thalassemia[PDF]
531HbSβVARIANT IIβ-thal Short Program45.94.45Compound heterozygote for HbS and HbC[PDF]
532HbCβVARIANT IIβ-thal Short Program44.65.17Compound heterozygote for HbS and HbC[PDF]
538Hb D-PunjabβVARIANT IIβ-thal Short Program414.06compound heterozygote for HbS and Hb D-Punjab[PDF]
539HbSβVARIANT IIβ-thal Short Program374.42compound heterozygote for HbS and Hb D-Punjab[PDF]
544HbCβVARIANT IIβ-thal Short Program60.55.15HbC and (delta-beta) O thal[PDF]
548HbCβVARIANT IIβ-thal Short Program61.85.16heterozygote[PDF]
550Hb Goudaα2VARIANT IIβ-thal Short Program31.11.7heterozygote[PDF]
554Hb A2' or Hb B2δVARIANT IIβ-thal Short Program4.550.9[PDF]
557Hb N-BaltimoreβVARIANT IIβ-thal Short Program81.31.61[PDF]
561HbSβVARIANT IIβ-thal Short Program32.54.46[PDF]
566HbEβVARIANT IIβ-thal Short Program51.63.69[PDF]
572HbCβVARIANT IIβ-thal Short Program47.75.15compound heterozygote for HbC and Hb O-Arab[PDF]
573Hb O-ArabβVARIANT IIβ-thal Short Program46.14.9Compound heterozygote for HbC and Hb O-Arab[PDF]
578Hb Mexicoα1 or α2VARIANT IIβ-thal Short Program27.71.82[PDF]
583HbIα1VARIANT IIβ-thal Short Program14.91.4heterozygote[PDF]
587Hb Lepore-Boston-WashingtonδVARIANT IIβ-thal Short Program11.13.55[PDF]
587Hb Lepore-Boston-WashingtonβVARIANT IIβ-thal Short Program11.13.55[PDF]
591Hb M-Milwaukee-2βVARIANT IIβ-thal Short Program34.15.15[PDF]
595Hb Lepore-Boston-WashingtonδVARIANT IIβ-thal Short Program10.83.5[PDF]
595Hb Lepore-Boston-WashingtonβVARIANT IIβ-thal Short Program10.83.5[PDF]
597HbIα1VARIANT IIβ-thal Short Program18.11.43[PDF]
601Hb Aichiα1 or α2VARIANT IIβ-thal Short Program21.14.33[PDF]
610Hb Setifα2VARIANT IIβ-thal Short Program13.24.74[PDF]
612HbSβVARIANT IIβ-thal Short Program37.94.46[PDF]
613Hb Montgomeryα2VARIANT IIβ-thal Short Program6.34.98[PDF]

Please Contact Us to provide new HPLC data and/or report mistakes.

Disclaimer: The HPLC images are provided by Bio-Rad Laboratories, Inc as an information resource only. Bio-Rad Laboratories, Inc and the ITHANET Portal disclaim responsibility and have no liability if this information is used for diagnostic or treatment purposes. D-10™ and VARIANT™ are registered trademarks of Bio-Rad Laboratories, Inc. and used with permission. Redistribution and use of the above material is allowed only with permission by Bio-Rad Laboratories, Inc.

Future events

  • MOLECULAR DIAGNOSTICS EUROPE
  • Third Annual Cell-Free DNA in Clinical Oncology
  • Third Annual Enabling Technologies for Cell-Free DNA
  • GENE THERAPY FOR RARE DISORDERS 2017
  • Pan-European Consensus Conference on Newborn Screening for Haemoglobinopathies

View all events

Find Us